Q2 2022 Holdings
Filed 2022-08-11 | 8 holdings | $65.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $30.3K | 498,558 | 46.4% |
| Passage Bio, Inc. | Common Stock | 702712100 | $11.7K | 4,959,769 | 17.9% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $8.6K | 3,561,150 | 13.2% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $6.1K | 5,068,233 | 9.3% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $3.9K | 1,673,700 | 6.0% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $2.8K | 2,320,381 | 4.3% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.6K | 543,753 | 2.5% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $183 | 101,855 | 0.3% |